ACE1702 in Subjects With Advanced or Metastatic HER2-expressing Solid Tumors

Clinical trial NCT04319757 · COMPLETED

Trial details

NCT number: NCT04319757
Sponsor: Acepodia Biotech, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Locally Advanced Solid Tumor Metastatic Cancer Solid Tumor HER2-positive Gastric Cancer HER2-positive Metastatic Breast Cancer

Start date: 2020-06-24
Primary completion: 2024-07-15
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.